BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, LaPolla J, Hoffman M, Martino MA, Wakeley K, Wilbanks G, Nicosia S, Cantor A, Sutphen R.
Pal T, et al.
Cancer. 2005 Dec 15;104(12):2807-16. doi: 10.1002/cncr.21536.
Cancer. 2005.
PMID: 16284991
Free article.